Presentations
–
Presentations.
| Date | Title | Files |
|---|---|---|
|
Nov 9, 2026
|
PIKTOR Phase 2 Endometrial Cancer Topline Results November 2026
|
|
|
Nov 9, 2026
|
Faeth Corporate Presentation November 2026
|
|
|
Oct 6, 2026
|
Inaugural Investor/ Analyst Day Presentation October 2026
|
|
|
Aug 8, 2026
|
Exposure/Response Analysis of an Oral Multi-Node PI3K/AKT/mTOR Pathway Inhibitor Combination of Serabelisib and Sapanisertib
|
Events
–
Past events.
Nov
09
2026
Virtual Event: PIK-201 Phase 2 Data in Advanced Endometrial Cancer
Supporting Materials
Oct
06
2026
Virtual KOL Event: Multi-Nodal Inhibition for the Treatment of Endometrial Cancer
Supporting Materials